← Leaderboards
Deborah Kwon
Cleveland Clinic Lerner Com-Cwru
$2,357,020
Attributed
$2,357,020
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $793.9K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$2,357,020 · 1
By mechanism
R01$2,357,020 · 1
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Mina Kay Chung$7,078,575
- Jacob Gardinier Scott$5,304,525
- Eugene Blackstone$4,436,208
- John Barnard$5,861,604
- Wai Hong Wilson Tang$15,125,003
Others in their field
Other Rising Stars on “Analytical Method”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Supriya Menezes · The Emmes Company, Llc$18,307,989
- Kevin V Grimes · Stanford University$14,783,804
- Atul Butte$13,028,424
- Venkata Mangalampalli · Leidos Biomedical Research, Inc.$11,756,555
- Sophia Zanakos · Icf, Inc., Llc$10,014,539
Research focus
Analytical MethodBiologicalAnatomyCardiacCardiac Magnetic Resonance ImagingCardiomyopathiesBiological HeterogeneityCharacteristicsClassificationClinical HeterogeneityClinically RelevantClinical TrialsComplexConsensusDatabasesCardiovascular SystemDevicesDimensionsDisease ClassificationDisease-Free SurvivalEchocardiographyEvolutionGuidelinesHeart Failure
Grant awards (3)
Improving Phenotypic Classification and Prediction of Treatment Outcomes in Patients with Non-ischemic Cardiomyopathy and Functional Mitral Regurgitation$785,673
R01 · FY2025 · HL · contact PI
Improving Phenotypic Classification and Prediction of Treatment Outcomes in Patients with Non-ischemic Cardiomyopathy and Functional Mitral Regurgitation$793,920
R01 · FY2024 · HL · contact PI
Improving Phenotypic Classification and Prediction of Treatment Outcomes in Patients with Non-ischemic Cardiomyopathy and Functional Mitral Regurgitation$777,427
R01 · FY2023 · HL · contact PI